Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺52.497, with a 24-hour trading volume of ₺102,2B. The asset's market cap is ₺46,81T, after moving -2.41% in the last day.
Tokenized Eli Lilly And Co is trading at ₺52.750,52, with a tokenized market cap of ₺2,06B and a 24-hour trading volume of ₺114,32M. The tokenized asset has moved 1.67% in the past 24 hours.